Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
l-Type amino acid transporter 1 in hypothalamic neurons in mice maintains energy and bone homeostasis
Gyujin Park, Kazuya Fukasawa, Tetsuhiro Horie, Yusuke Masuo, Yuka Inaba, Takanori Tatsuno, Takanori Yamada, Kazuya Tokumura, Sayuki Iwahashi, Takashi Iezaki, Katsuyuki Kaneda, Yukio Kato, Yasuhito Ishigaki, Michihiro Mieda, Tomohiro Tanaka, Kazuma Ogawa, Hiroki Ochi, Shingo Sato, Yun-Bo Shi, Hiroshi Inoue, Hojoon Lee, Eiichi Hinoi
Gyujin Park, Kazuya Fukasawa, Tetsuhiro Horie, Yusuke Masuo, Yuka Inaba, Takanori Tatsuno, Takanori Yamada, Kazuya Tokumura, Sayuki Iwahashi, Takashi Iezaki, Katsuyuki Kaneda, Yukio Kato, Yasuhito Ishigaki, Michihiro Mieda, Tomohiro Tanaka, Kazuma Ogawa, Hiroki Ochi, Shingo Sato, Yun-Bo Shi, Hiroshi Inoue, Hojoon Lee, Eiichi Hinoi
View: Text | PDF
Research Article Bone biology Endocrinology

l-Type amino acid transporter 1 in hypothalamic neurons in mice maintains energy and bone homeostasis

  • Text
  • PDF
Abstract

Hypothalamic neurons regulate body homeostasis by sensing and integrating changes in the levels of key hormones and primary nutrients (amino acids, glucose, and lipids). However, the molecular mechanisms that enable hypothalamic neurons to detect primary nutrients remain elusive. Here, we identified l-type amino acid transporter 1 (LAT1) in hypothalamic leptin receptor–expressing (LepR-expressing) neurons as being important for systemic energy and bone homeostasis. We observed LAT1-dependent amino acid uptake in the hypothalamus, which was compromised in a mouse model of obesity and diabetes. Mice lacking LAT1 (encoded by solute carrier transporter 7a5, Slc7a5) in LepR-expressing neurons exhibited obesity-related phenotypes and higher bone mass. Slc7a5 deficiency caused sympathetic dysfunction and leptin insensitivity in LepR-expressing neurons before obesity onset. Importantly, restoring Slc7a5 expression selectively in LepR-expressing ventromedial hypothalamus neurons rescued energy and bone homeostasis in mice deficient for Slc7a5 in LepR-expressing cells. Mechanistic target of rapamycin complex-1 (mTORC1) was found to be a crucial mediator of LAT1-dependent regulation of energy and bone homeostasis. These results suggest that the LAT1/mTORC1 axis in LepR-expressing neurons controls energy and bone homeostasis by fine-tuning sympathetic outflow, thus providing in vivo evidence of the implications of amino acid sensing by hypothalamic neurons in body homeostasis.

Authors

Gyujin Park, Kazuya Fukasawa, Tetsuhiro Horie, Yusuke Masuo, Yuka Inaba, Takanori Tatsuno, Takanori Yamada, Kazuya Tokumura, Sayuki Iwahashi, Takashi Iezaki, Katsuyuki Kaneda, Yukio Kato, Yasuhito Ishigaki, Michihiro Mieda, Tomohiro Tanaka, Kazuma Ogawa, Hiroki Ochi, Shingo Sato, Yun-Bo Shi, Hiroshi Inoue, Hojoon Lee, Eiichi Hinoi

×

Figure 6

Bone homeostasis is regulated by LAT1 in LepR-expressing cells.

Options: View larger image (or click on image) Download as PowerPoint
Bone homeostasis is regulated by LAT1 in LepR-expressing cells.
(A) Micr...
(A) Micro–computed tomography (μCT) analysis (scale bar, 1 mm); (B) bone volume over tissue volume (BV/TV) ratio as determined by μCT (n = 12 or 13, *P < 0.05, 2-tailed Student’s t test); (C) von Kossa stain, scale bar, 1 mm; (D) BV/TV ratio as determined by von Kossa stain (n = 5 or 6, *P < 0.05, 2-tailed Student’s t test); (E) number of osteoblasts/tissue area ratio (n = 5 or 6, **P < 0.01, 2-tailed Student’s t test); (F) calcein labeling (scale bar, 50 μm); (G) bone formation rate (n = 5 or 6, *P < 0.05, 2-tailed Student’s t test); (H) TRAP stain (scale bar, 50 μm; arrowheads indicate TRAP-positive osteoclasts); and (I) osteoclast surface/bone surface ratio of femurs from LepR-Cre Slc7a5fl/fl mice and control mice at 12–16 weeks of age (n = 3 to 5, **P < 0.01, 2-tailed Student’s t test). TRAP, tartrate-resistant acid phosphatase. (J) μCT analysis, scale bar, 1 mm and (K) BV/TV ratio as determined by μCT of femurs from LepR-Cre Slc7a5fl/fl mice administrated with isoproterenol at 14 weeks of age (n = 10, **P < 0.01, #P < 0.05, 2-tailed Student’s t test with Benjamini-Hochberg correction). (L) Representative images of CFU assays stained with crystal violet and alizarin red (scale bar, 500 μm), (M) mRNA level of Slc7a5 in BM-MSCs (n = 4, **P < 0.01, 2-tailed Student’s t test), and (N and O) quantification of CFU assays stained with crystal violet (N) and alizarin red (O) (n = 6 to 9, **P < 0.01, ***P < 0.001, 2-tailed Student’s t test) in LepR-Cre Slc7a5fl/fl mice at 6 weeks of age. All the mice used in this study were male.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts